Sex steroid hormones, hormonal contraception, and the immunobiology of human immunodeficiency virus-1 infection.
about
Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysisHormonal contraception for women exposed to HIV infectionHormonal contraception for women exposed to HIV infectionAdvances in HIV microbicide developmentResearch gaps in defining the biological link between HIV risk and hormonal contraceptionContraceptive methods and risk of HIV acquisition or female-to-male transmissionThe complexity of contraceptives: understanding their impact on genital immune cells and vaginal microbiota.Recent Insights into the HIV/AIDS Pandemic.Injectable and oral contraceptives and risk of HIV acquisition in women: an analysis of data from the MDP301 trial.17β-estradiol protects primary macrophages against HIV infection through induction of interferon-alpha.The injectable-only contraceptive medroxyprogesterone acetate, unlike norethisterone acetate and progesterone, regulates inflammatory genes in endocervical cells via the glucocorticoid receptor.A randomized clinical trial on the effects of progestin contraception in the genital tract of HIV-infected and uninfected women in Lilongwe, Malawi: Addressing evolving research priorities.Sex influences immune responses to viruses, and efficacy of prophylaxis and treatments for viral diseasesNanoparticle-based drug delivery to the vagina: a review.Hormonal contraception and HIV acquisition: reanalysis using marginal structural modelingProductive HIV-1 infection of human cervical tissue ex vivo is associated with the secretory phase of the menstrual cycle.Fcgbp - A Potential Viral Trap in RV144Medroxyprogesterone acetate differentially regulates interleukin (IL)-12 and IL-10 in a human ectocervical epithelial cell line in a glucocorticoid receptor (GR)-dependent mannerPreexposure prophylaxis is efficacious for HIV-1 prevention among women using depot medroxyprogesterone acetate for contraceptionThe progestin-only contraceptive medroxyprogesterone acetate, but not norethisterone acetate, enhances HIV-1 Vpr-mediated apoptosis in human CD4+ T cells through the glucocorticoid receptor.Hormonal contraception is associated with a reduced risk of bacterial vaginosis: a systematic review and meta-analysisDistinct characteristics of endometrial and decidual macrophages and regulation of their permissivity to HIV-1 infection by SAMHD1.Contraception in HIV-positive female adolescents.Quotidian changes of genital tract cytokines in human immunodeficiency virus-1-infected women during the menstrual cycle.Effects of chronic HIV-1 Tat exposure in the CNS: heightened vulnerability of males versus females to changes in cell numbers, synaptic integrity, and behaviorSex differences in HIV RNA level and CD4 cell percentage during childhoodMolecular mechanisms linking high dose medroxyprogesterone with HIV-1 risk.Depot Medroxyprogesterone Acetate Use Is Associated With Elevated Innate Immune Effector Molecules in Cervicovaginal Secretions of HIV-1-Uninfected WomenA long-acting integrase inhibitor protects female macaques from repeated high-dose intravaginal SHIV challenge.Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study.Characterization of the Genital Microenvironment of Female Rhesus Macaques Prior to and After SIV InfectionRisk Factors for HIV Acquisition in High Risk Women in a Generalised Epidemic Setting.Hormone replacement therapy and risk for neurodegenerative diseases.Estradiol Enhances CD4+ T-Cell Anti-Viral Immunity by Priming Vaginal DCs to Induce Th17 Responses via an IL-1-Dependent PathwayProgesterone and autoimmune disease.Trends in contraceptive use among women with human immunodeficiency virusBrief Report: Hormonal Contraception Is Not Associated With Reduced ART Effectiveness Among Women Initiating ART: Evidence From Longitudinal Data.Living with uncertainty: acting in the best interests of womenAlcohol use, mycoplasma genitalium, and other STIs associated With HIV incidence among women at high risk in Kampala, Uganda.Hormonal contraception and HIV-1 infection: medroxyprogesterone acetate suppresses innate and adaptive immune mechanisms
P2860
Q21144588-E362F4B3-5DDC-4EF6-A7D1-A867DB2E2348Q24194597-A29F1E66-BB4D-4203-A9ED-9E3DC498DA63Q24201661-D003CFE8-A63A-4443-98EF-497A911DAE36Q26852858-02CF666C-80E0-4535-8D24-666084799F64Q27002559-6D321CBC-5A54-455D-AF6A-E1881BCA1B0AQ27027323-DAE77BB9-E18F-4E56-B7D8-AC8C6EEB0505Q27692596-DE098E41-1ED5-4674-B8C2-3E893BD24811Q30235024-26E895E3-5418-4592-A90E-1FEF0BEC7AFAQ30823365-2BF9274E-975E-49C0-AF7E-BB3F97A69D0CQ33631612-41F36B70-82E3-47E9-A5A3-4636BEFF091CQ33631772-863A912F-B141-48FA-8DB1-2055DA2F6695Q33763511-CBC44C1C-100E-47E8-BBC3-BA344EE4ED16Q33997400-E8D51CC7-6D17-4ADB-BC32-BC8045C5F4F0Q34079533-61800C89-087A-4EC4-B2D8-C4E99D954F83Q34123283-5F7027FF-BA8B-4DB9-B1B2-4D096457B6E0Q34127684-9CAADB35-CA26-4A9B-A8F0-2E2E7A5297C3Q34201287-9A85CEE4-7FE3-4D1E-8B71-24454E6A229FQ34467518-9FED23BE-1E22-43FA-BDAA-2E2BFEC3D65EQ34700364-94552393-CD19-419F-AA44-C9A77DEFF455Q34712821-BC32FF9A-51FC-447A-9D31-BF8501B1FDDCQ34984200-EDE7F4F4-4C78-400E-9832-5428560D5902Q34991106-8E5A32A2-E1F2-4F13-8E6C-A61F58C96D42Q35068065-69E9F462-4A1F-4EA4-A268-1007A08D9F32Q35071985-F028A764-619A-433E-A481-09862E96F6BEQ35123216-64863728-85AC-4B11-A40E-6A7E285C38B5Q35178669-88B75A05-EE2A-4312-95BF-16AD957D84ECQ35208283-488EFA39-7D08-46C9-A0F1-2584ED04EAADQ35582308-DBD8A50A-4267-4EBD-99A5-CA9739B94E3CQ35667426-5612B5B5-B0EE-41AE-AAA3-4614BC00CC20Q35699938-EDFBB3AE-B103-4DB6-9BF7-6894FFC7B730Q35750861-DE64D60A-675F-49A8-AAC0-B54639F69416Q35862772-1A57A7EB-8B3E-4D3D-9B6E-D98E967AE280Q35884815-F07D80F1-56A5-4015-A328-509319617A34Q36009231-E18F7632-49C0-4657-9C4D-B2CB4BBB6EBBQ36202227-88FA2C78-77DE-4282-8A41-27BFD87EDA3BQ36253393-A49768CA-0A7E-4813-98D9-CD613FCD707CQ36343568-2C33027A-73C5-4AB6-AD21-988749D25DDAQ36410468-79DF4FBA-D8F5-4E87-BD41-2DD40C96B38AQ36487808-3CC3246C-7ACB-4771-A5DF-4AE6FEB3B5C8Q36628484-614BEE09-76B1-4327-A215-D9E666D28557
P2860
Sex steroid hormones, hormonal contraception, and the immunobiology of human immunodeficiency virus-1 infection.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Sex steroid hormones, hormonal ...... odeficiency virus-1 infection.
@ast
Sex steroid hormones, hormonal ...... odeficiency virus-1 infection.
@en
type
label
Sex steroid hormones, hormonal ...... odeficiency virus-1 infection.
@ast
Sex steroid hormones, hormonal ...... odeficiency virus-1 infection.
@en
prefLabel
Sex steroid hormones, hormonal ...... odeficiency virus-1 infection.
@ast
Sex steroid hormones, hormonal ...... odeficiency virus-1 infection.
@en
P2860
P356
P1433
P1476
Sex steroid hormones, hormonal ...... odeficiency virus-1 infection.
@en
P2093
Elizabeth Stringer
Jiri Mestecky
P2860
P356
10.1210/ER.2009-0018
P50
P577
2009-11-10T00:00:00Z